主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NUVB
#3995
Nuvation Bio Inc.
5.9
2
+5.71%
版块:
基础:
利润货币:
日范围
年范围
日变化
+5.71%
每月变动
+5.53%
6个月变化
+98.66%
年变化
+203.59%
前一天收盘价
5.6
0
Open
5.7
9
Bid
Ask
Low
5.7
9
High
5.9
2
交易量
1 640
市场
股票
医疗保健
NUVB
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
335.25 M
337.68 M
336.84 M
336.84 M
336.84 M
—
Valuation ratios
Enterprise value
740.7 M
1.77 B
656.57 M
472.02 M
1.22 B
4.12 B
Price to earnings ratio
-1
-1.26
-0.77
-4.06
-7.55
-13.64
Price to sales ratio
0.29
0.09
0.05
0.04
0.04
0.22
Price to cash flow ratio
0.01
0.01
0
0
0.01
0.02
Price to book ratio
0
0
0
0
0
0
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.07
-0.09
-0.11
-0.09
-0.09
-0.38
Return on equity %
-0.08
-0.11
-0.13
-0.16
-0.17
-0.56
Return on invested capital %
-608.13
-683.06
-687.1
-642.14
-511.99
-2 524.3
Gross margin %
84.18
26.18
32.1
46.7
74.47
179.45
Operating margin %
-6 616.37
-944.53
-1 913.23
-1 315.73
-430.14
-4 603.62
EBITDA margin %
—
—
—
—
-428.51
—
Net margin %
-5 668.5
-865.79
-1 726.2
-1 220.92
-425.24
-4 238.15
Liquidity ratios
Quick ratio
—
—
9.01
9.38
8.39
—
Current ratio
9.57
9.04
9.01
9.39
8.48
35.92
Inventory turnover
—
—
149.57
9.1
1.07
—
Asset turnover
0
0.01
0.01
0.01
0.02
0.05
Solvency ratios
Debt to assets ratio
—
—
0.21
0.08
0.09
—
Debt to equity ratio
—
—
0.25
0.14
0.16
—
Long term debt to total assets ratio
—
—
0.2
0.07
0.08
—
Long term debt to total equity ratio
—
—
0.24
0.13
0.14
—
Per share metrics
Operating cash flow per share
-126.42
-172.27
-125.89
-141.83
-155.28
-595.27
EBIT per share
-195.62
-200.7
-174.25
-187.2
-165.69
-727.84
EBITDA per share
—
—
—
—
-165.07
—
Total debt per share
—
—
312.11
154.72
154.75
—
Cash per share
2 233.3
1 870.33
1 363.44
1 789.08
1 612.01
6 634.85
Net current asset value per share
2 297.76
1 958
1 404.46
1 834.66
1 695.64
6 892.76
Tangible book value per share
2 033.21
1 708.38
1 225.74
1 062.05
922.5
4 918.68
Working capital per share
2 057.67
1 741.29
1 248.61
1 639.32
1 495.61
6 124.83
Book value per share
2 044.51
1 725.58
1 238.76
1 097.8
956.8
5 018.94
新闻
Regenxbio (RGNX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Tracking David Abrams' Abrams Capital Management Portfolio - Q4 2025 Update
Nuvation Bio expands SIGMA trial to phase 3 for IDH1-mutant glioma
Nuvation Bio股票因Ibtrozi销售势头强劲维持B.Riley买入评级
Nuvation Bio stock maintains Buy rating at B.Riley on Ibtrozi sales momentum
Nuvation Bio: Rollout Data Of Ibtrozi Support A Modest Buy (NYSE:NUVB)
Truist Securities上调Nuvation Bio股票目标价至13美元,看好Ibtrozi市场表现
Truist Securities raises Nuvation Bio stock price target to $13 on Ibtrozi uptake
Jones Trading raises Nuvation Bio stock price target to $12 on safusidenib study
Down 24% in 4 Weeks, Here's Why Nuvation Bio (NUVB) Looks Ripe for a Turnaround
H.C. Wainwright下调Nuvation Bio目标价至17美元
Nuvation Bio stock price target lowered to $17 at H.C. Wainwright